Wall Street Zen upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a hold rating to a buy rating in a research report released on Saturday,Wall Street Zen reports. Several other research firms also recently issued reports on COLL. Piper Sandler dropped their price target on Collegium Pharmaceutical from $43.00 to $28.00 and set […]